Phase 3 Synovial Sarcoma Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
LeiomyosarcomaSynovial SarcomaAlveolar Soft Part Sarcoma
Advenchen Laboratories, LLC325 enrolled24 locationsNCT03016819
Recruiting
Phase 3
Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma
Synovial Sarcomas
Takara Bio Inc.5 enrolled2 locationsNCT07174427